YAG MIR FAMILY LASER

K053421 · Cynosure, Inc. · GEX · Feb 1, 2006 · General, Plastic Surgery

Device Facts

• Record ID: K053421
• Device Name: YAG MIR FAMILY LASER
• Applicant: Cynosure, Inc.
• Product Code: GEX · General, Plastic Surgery
• Decision Date: Feb 1, 2006
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.4810
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Cynosure YAG MIR Family Laser is indicated for permanent hair reduction and the treatment of vascular and pigmented lesions and wrinkles.

Device Story

Cynosure YAG MIR Family Laser is a Nd:YAG laser system utilizing a Nd:YAG crystal rod as the lasing medium. It operates at 1064nm and 1440nm wavelengths. The device is activated via footswitch or finger switch by a clinician in a clinical setting. It delivers laser energy to target soft tissue for surgical applications (incision, excision, ablation, vaporization, coagulation, hemostasis) or dermatological treatments (hair reduction, lesion removal, wrinkle reduction). The system is a floor-standing unit weighing 285 lbs, requiring 220 VAC power. By targeting melanin in hair follicles or specific vascular/pigmented structures, the laser provides therapeutic effects for skin conditions and unwanted hair. Clinicians use the device to perform procedures that improve patient aesthetic appearance or treat dermatological pathologies.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Nd:YAG laser system; 1064nm and 1440nm wavelengths; Nd:YAG crystal rod medium; 220 VAC, 30A, 50-60 Hz power; footswitch/finger switch activation; dimensions 41"x18"x32"; weight 285 lbs.

Indications for Use

Indicated for adults requiring coagulation/hemostasis of vascular lesions (port wine stains, hemangiomas, warts, telangiectasia, rosacea, venous lakes, scars, striae, psoriasis, poikiloderma of Civatte); treatment of benign pigmented lesions (lentigos, solar lentigos, Café au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, tattoos); treatment of wrinkles (periocular, perioral); removal of unwanted hair; and treatment of pseudofolliculitis barbae (PFB). Also indicated for general surgery/dermatology use (incision, excision, ablation, vaporization, coagulation, hemostasis of soft tissue).

Regulatory Classification

Identification

(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

Predicate Devices

• Cynosure YAG Family laser

Submission Summary (Full Text)

{0}------------------------------------------------

にER) 2006

K 053421

## 510(K) Summary

| Submitter: | Cynosure, Inc.<br>5 Carlisle Road<br>Westford, MA 01886 |
|-------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact: | George Cho<br>Senior Vice President of Medical Technology |
| Date Summary Prepared: | December 7, 2005 |
| Device Trade Name: | Cynosure YAG MIR Family Laser |
| Common Name: | Medical Laser System |
| Classification Name: | Instrument, surgical, powered, laser<br>79-GEX<br>21 CFR 878.4810 |
| Equivalent Device: | The Cynosure YAG Family laser |
| Device Description: | The Cynosure YAG MIR Family laser is a Nd:YAG laser, having a<br>ND:YAG crystal rod as a lasing medium.<br>Laser activation is by footswitch or finger switch. Overall weight of<br>the laser is 285lbs, and the size is 41"x18"x32" (HxWxD).<br>Electrical requirement is 220 VAC, 30A, 50-60 Hz, single phase. |
| Intended Use: | The Cynosure YAG MIR Family Laser is indicated for permanent hair<br>reduction and the treatment of vascular and pigmented lesions and<br>wrinkles. |
| Comparison: | The Cynosure YAG MIR Family Laser has the same indications for<br>use, the same principle of operation, and similar wavelengths and<br>pulse energy range as the predicate device(s). |
| Nonclinical Performance Data: | none |
| Clinical Performance Data: | none |
| Conclusion: | The Cynosure YAG MIR Family Laser is a safe and effective device<br>for the indications specified. |
| Additional Information: | none |

{1}------------------------------------------------

Image /page/1/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS). The seal features a stylized eagle with three lines forming its body and wings. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES USA" is arranged in a circular pattern around the eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

FEB 1 2006

Mr. George Cho Senior Vice President Medical Technology Cynosure, Inc. 5 Carlisle Road Westford, Massachusetts 01886

Re: K053421 K053421
Trade/Device Name: Cynosure YAG MIR Family Laser Frade/Dovider: 21 CFR 878.4810 Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: GEX Dated: December 7, 2005 Received: December 9, 2005

Dear Mr. Cho:

We have reviewed your Section 510(k) premarket notification of intent to market the device
s and the many of the county of the device is substantially equivalent (for the ind We have reviewed your Section > I'v(x) premium in the minutent (for the indications
referenced above and have determined the device is substantially interstate referenced above and have delemined the devices marketed in interstate
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use stated in the enclosure) to legily manced te of the Medical Device Amendments, or to
commerce prior to May 28, 1976, the enactment the organison of the Federal Food. commerce prior to May 28, 1976, the enactively with the provisions of the Federal Food. Drug,
devices that have been reclassified in accordance with the provisions of the Fed devices that have been reclassified in accordance while in the proval application (PMA).
and Cosmetic Act (Act) that do not require approval control enonvisions of the Act. and Cosmetic Act (Act) that do not require approval or a provisions of the Act. The
You may, therefore, market the device, subject to the general constructions of the Act. You may, therefore, market the uevice, subject to the genting for annual registration, listing of
general controls provisions of the Act include requirements mishranding and general controls provisions of the Act mende requirements of the security misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), If your device is classified (see a000) into chief regulations affecting your device
it may be subject to such additional controls. Existing major regulations FDA it may be subject to such additions. Extrails includes of the 800 to 898. In addition, FDA
can be found in the Code of Federal Regulations, Title 21, Parts 800 to Angel can be found in the Code of Federal Regalations, The Bedgral Register.

Please be advised that FDA's issuance of a substantial equivalence determination docs not mean Please be advised that FDA s Issualited on a substitution with other requirements of the Act
that FDA has made a determination that your device also accepcies . You must that FDA has made a determination mat your de ros seem agencies. You must or any Federal statutes and regulations administration of the tregistration and listing (21
comply with all the Act's requirements, including, but not to regurements as set comply with all the Act s requirements, mendams, out manufacturing practice requirements as school CFR Part 807); labeling (21 CFR Part 801); good and if applicable, the electronic
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, 1960 forin in the quality systems (QD) regulations (Sections 531-542 of the Act); 21 CFR 1000-1050.
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000

{2}------------------------------------------------

Page 2 -- Mr. Cho

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Barbara Buehrig

Mark N. Melkerson Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

510(k) Number (if known): _

Device Name: _ Cynosure YAG MIR Family Laser

Indications For Use:

1064nm: The Cynosure YAG MIR Family laser is intended for the coagulation and hemostasis of 1004mm. The Cynosure 1710 mitted to, port wine stains, hemangiomas, warts, belligh vascular icsions, such as , out hovement and poikiloderma of civatte; and treatment of telangicolasia, rosacca, vehas sates, scars, stiae and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), Café au lait macules, seborrheic keratoses, nevi, chloasma, verrucea, skin tags, keratoses, tattoos spors), Caro an fair masures, of black and/or blue/black tattoos) and plaques.

The laser is also indicated for the treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles.

Additionally, the laser is indicated for the removal of unwanted hair, for the stable long term, or Adultionally, the laser is marbated for attreating of melanin in the hair follicles, and for the treatment of pseudofolliculitis barbae (PFB).

1440mm: The Cynosure YAG MIR Family laser is indicated for use in general surgery and dermatology for the incision, excision, ablation, vaporization, coagulation and hemostasis of soft tissue. It is also ior the meision, oneible, actuacia, winkles and perioral wrinkles and pigmented lesions.

> Over-The-Counter Use X OR Prescriptive Use (Part 21 CFR 801 Subpart C) (Part 21 CFR 801 Subpart D)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Carlene Beecher Der MKM

Division of General. Restorative, and Neurological Desires

510(k) Number_ (05 542 _